BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

InferMed appoints new Director of Product Development to Executive Team

London, UK, 13 Nov 2007…….InferMed Ltd, a leading provider of advanced software solutions for clinical research and practice, today announced the appointment of seasoned IT executive, Martin Rouen to the position of Director of Product Development with immediate effect.

In this position, Mr. Rouen will report directly to InferMed’s Chief Executive Officer, Duane Lawrence, where his focus will be to spearhead product development and enhancements in development processes in order to improve customer satisfaction through the effective and timely delivery of world class products.

Martin joins InferMed from Alphameric Solutions Ltd, where he held the role of Program and Development Manager, with responsibility for the full software development lifecycle for a series of products through to ensuring their successful deployment. In this role Mr. Rouen was instrumental in instigating adoption of new software tools and methodologies which facilitated the redesign of the entire software development lifecycle ensuring speedy delivery of new releases to the client resulting in greatly improved customer satisfaction ratings for the organization. Martin also served as Senior Technical Designer and Departmental Head at “Domestic & General” and “MOD UK” respectively.

Commenting on his appointment, Martin Rouen said: “I am thrilled to be given the opportunity to work with the team at InferMed and have already been warmly welcomed by everyone there. Exciting challenges lie ahead and I look forward to assisting in the enhancement of the current excellent product lines being developed by InferMed.”

Duane Lawrence, CEO of InferMed, said: “This appointment marks a significant step in the expansion of InferMed. With his excellent track record in innovative product development and deployment, Martin will be critically important in driving forward InferMed’s plan to significantly raise the level of discipline and focus in our development efforts whilst ensuring improved customer satisfaction through the effective delivery of world class products. Martin will be responsible for addressing both the solutions of today and building a world class structure and team to address our aggressive future growth needs.”

Mr. Lawrence continued “We believe that the market is now perfectly positioned for effective personalised clinical decision support solutions, both stand alone and those embedded within EDC and EMR solutions. As such, it is now time to aggressively develop and market customer-centric solutions that address current and future clinical needs.”

About InferMed Ltd
Formed in 1999 InferMed has become a global leader in providing software and services to the healthcare, pharmaceutical, and clinical research sectors with whom they work in close collaboration.

InferMed offers a range of highly innovative software solutions for collecting and managing data. Through both their MACRO EDC application and Arezzo® decision support technology, InferMed’s products are designed to improve patient outcomes and deliver personalised drug and other therapies to healthcare providers more efficiently.

For more information visit www.infermed.com

InferMed - Delivering The Future Of Clinical Software.

Ends

Media Contact:

Marie Tysall-Blay (on behalf of InferMed Ltd)
E-mail: marietysallblay@hotmail.com
Mob: +44 7765888100



 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.